Non-steroidal anti-inflammatory drugs for the common cold (Q24240072)

2

0 references

Ye-won Hwang

3

0 references

Yoo Sun Moon

4

0 references

Yoon-Jung Chang

Cochrane Database of Systematic Reviews

5

0 references

publication date

8 July 2009

0 references

published in

0 references

cites work

Influence of loxoprofen use on recovery from naturally acquired upper respiratory tract infections: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

A double-blind study of zaltoprofen for the treatment of upper respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Antipyretic and analgesic effects of zaltoprofen for the treatment of acute upper respiratory tract infection: verification of a noninferiority hypothesis using loxoprofen sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Efficacy and Tolerability of the Anti-inflammatory Throat Lozenge Flurbiprofen 8.75mg in the Treatment of Sore Throat : A Randomised, Double-Blind, Placebo-Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

A multi-centre, double-blind randomized study to assess the efficacy and tolerance of sulindac versus placebo in the symptomatic treatment of patients with upper respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Lowest effective single dose of diclofenac for antipyretic and analgesic effects in acute febrile sore throat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Therapeutic effects of fenbufen in common cold--multi-clinic double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Therapeutic Utility of NAPROXEN on Acute Upper Respiratory Infection-Multi-Clinical Double Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

A placebo-controlled model for assaying systemic analgesics in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Increased Virus Shedding With Aspirin Treatment of Rhinovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Assessment of the efficacy and safety of paracetamol, ibuprofen and nimesulide in children with upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Antipyretic efficacy of tiaprofenic acid in febrile children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Intranasal ipratropium bromide for the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Antihistamines for the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Oral antihistamine-decongestant-analgesic combinations for the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Understanding the symptoms of the common cold and influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Viral respiratory infection therapy: historical perspectives and current trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

The diagnosis and treatment of cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Acetaminophen (paracetamol) for the common cold in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Cough and the common cold: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

Nasal decongestants for the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

[Clinical evaluation of Clinoril tablets in acute upper respiratory tract infections]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

[Double blind controlled study of miroprofen in acute upper respiratory tract infections--comparison with ibuprofen]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

[Clinical evaluation of sulindac (CLINORIL) in the treatment of acute upper respiratory tract infection--double-blind comparison with ibuprofen]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

[A double-blind clinical evaluation of suprofen on acute upper respiratory infection. Comparison with aspirin]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

[A double-blind clinical evaluation of flurbiprofen on acute upper respiratory tract inflammation--comparative study with ibuprofen]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

[Clinical evaluation of oxaprozin in the treatment of acute upper respiratory tract inflammations--a double-blind comparative study using ibuprofen as the control drug]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

Nimesulide and antibiotics in the treatment of acute infections of the respiratory tract

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

Double-blind study of nimesulide in divers with inflammatory disorders of the ear, nose and throat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

Nimesulide granules for the treatment of acute inflammation of the ear, nose or throat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

Treatment of upper airways inflammation with nimesulide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

A double-blind comparison of nimesulide and mefenamic acid in the treatment of acute upper respiratory tract infections in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021

Efficacy and tolerability of nimesulide and lysine-acetylsalicylate in the treatment of paediatric acute upper respiratory tract inflammation.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006362.PUB2

7 January 2021